Diagnostic Testing for the Novel Coronavirus

被引：166

作者：

Sharfstein, Joshua M. ^{[1
]}

Becker, Scott J. ^{[2
]}

Mello, Michelle M. ^{[3
,4
]}

机构：

[1] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA

[2] Assoc Publ Hlth Labs, Silver Spring, MD USA

[3] Stanford Univ, Dept Med, Sch Med, Stanford Law Sch, Stanford, CA 94305 USA

[4] Stanford Univ, Dept Med, Sch Med, Ctr Hlth Policy Primary Care & Outcomes Res, Stanford, CA 94305 USA

来源：

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2020年 / 323卷 / 15期

关键词：

D O I：

10.1001/jama.2020.3864

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

This Viewpoint explains the technical and regulatory challenges that hampered diagnostic testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) during the early spread of infection in the US and considers the unintended consequences of making testing more widely available, including false-negative results and overtesting.

引用

页码：1437 / 1438

页数：2

共 5 条

[1]

[Anonymous], EV REP PERS INV PUI

[2] Maintaining Life-saving Testing for Patients With Infectious Diseases: Infectious Diseases Society of America, American Society for Microbiology, and Pan American Society for Clinical Virology Recommendations on the Regulation of Laboratory-developed Tests [J].

Caliendo, Angela M. ;

Couturier, Marc R. ;

Ginocchio, Christine C. ;

Hanson, Kimberly E. ;

Miller, Melissa B. ;

Walker, Kimberly E. ;

Frank, Gregory M. .

CLINICAL INFECTIOUS DISEASES, 2016, 63 (02) :151-154

[3] Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts [J].

Hellewell, Joel ;

Abbott, Sam ;

Gimma, Amy ;

Bosse, Nikos, I ;

Jarvis, Christopher, I ;

Russell, Timothy W. ;

Munday, James D. ;

Kucharski, Adam J. ;

Edmunds, W. John ;

Funk, Sebastian ;

Eggo, Rosalind M. .

LANCET GLOBAL HEALTH, 2020, 8 (04) :E488-E496

[4]

US Food and Drug Administration, 2020, INF LAB IMPL IVD TES

[5]

US Food and Drug Administration, 2020, POL DIAGN TEST LAB C

← 1 →